Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Primary Optic Nerve Sheath Meningioma_Jeremic, Pitz_2008

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
10.06 Mб
Скачать
978-3-540-77557-7_1_2008-08-06_1
Stereotactic fractionated radiation therapy combined advantages of stereotactic approach and biological advantages of fractionating the total tumour dose. While
Stereotactic Fractionated Radiation therapy
10.3
10.3.1.1
thomas Jefferson university, Philadelphia (uS) Approach
10.3.1
treatment techniques
in cases of pONSM, total tumour doses used usually ranged from 45 to 54 Gy, they have unequivocally been given using standard fractionation, e.g. 1.8–1.9 Gy per fraction. Different treatment techniques were used, described in detail below.
patients with a variety of intracranial tumors, all situated within 2 mm of a “short segment” of the optic apparatus. Of these, 39 patients underwent previous surgery and 6 had previously been treated with conventional fractionated radiation therapy. Cyber Knife delivered two to five sessions to an average tumor volume of 7.7 cm3 and a cumulative average marginal dose of 20.3 Gy. Formal visual testing and clinical examinations were done before treatment and at follow-up intervals beginning at 6 months. After a mean visual field follow-up of 49 months (range, 6–96 months), vision was unchanged post-radiosurgery in 38 patients, improved in 8 (16%), and worse in 3 (6%). In each instance, visual deterioration was accompanied by tumor progression that ulti-
mately resulted in patient death. These results showed This part of the chapter summarizes experience of that fractionated (multisession) radiosurgery may result Thomas Jefferson University, Kimmel Cancer Centre, in preservation of visual function in patients with periDepartment of Radiation Oncology with the X-Knife/ optic tumors. While there are no data confirming these Varian 600SR SRS/SRT system and more recently with observations in patients with ONSM, it remains the BrainLab/NovalisPROOFSSRT systems for optic nerve sheath subject of speculative optimism to consider this techmeningioma. We describe the treatment planning and nique in selected pONSM. Furthermore, recent report delivery with multiple isocenter using circular collimaby Romanelli et al. (2007) presented initial data on tors of the X-Knife system and delivery with a single three patients with pONSM (two intraorbital and one isocenter using the Novalis micro-multileaf collimator. intracanalicullar patient) diagnosed based on neuroimWe commissioned an X-Knife/Varian 600SR 6MV aging only; no biopsy was performed. In all three palinearD accelerator designed for and dedicated to stereotients, slow but appreciable impairment in visual func- Etactic radiosurgery and fractionated stereotactic radiotioning was observed. Treatment was instituted withttherapy in 1994 (Das et al. 1996) This unit was used 20 Gy given in 4 fractions being prescribed as an C80% from its inception to treat various benign central nerisodose in 4 days. Imaging was repeated every 6 Emonths vous system tumours, such as acoustic schwannomas, and thorough neuroophthalmological evaluationR was non-acoustic schwannomas, meningiomas (including performed every 3 months. While no changesR in lesion optic nerve sheet meningiomas, ONSM), pituitary tusize was observed over time on serial images, progresmours, craniopharyngiomas and others with SRT, using sive improvement in visual fields andCOacuity was docustandard daily fractions of 1.8 Gy (rarely, 2.0 Gy). Total mented in all three patients. AfterN1 year, full restoration doses ranged from 50.4 to 54 Gy.
to normal vision was diagnosed in all patients. Visual Patients are referred mostly from the neighbouring fields and acuity restorationuhave remained stable for Wills Eye Hospital in Philadelphia and the Department 42, 32, and 30 months, respectively, since the irradiation. of Neurological Surgery of Thomas Jefferson UniverNo information, unfortunately, was provided regardsity Hospital. Their cases are presented and discussed ing the side-effects of such treatment, although authors at the weekly Stereotactic Tumour Board, attended by discussed “safety” of their fractionation regimen as opthe neurosurgeons, radiation oncologists, neuroradiposed to “more aggressive” regimen of 21 Gy delivered ologists, and neurooncologists. Treatment recommenin three fractions which have led to loss of vision in one dations are given as agreed by all members of the Tupatient in the series of Adler et al. (2006). mour Board. Most patients with ONSM were diagnosed
based on imaging criteria only, although very few had had prior surgical procedures. They were treated with SRT irrespective of the degree of vision preservation on presentation, with only single patients receiving SRS in the blind eye. Pre-treatment evaluation consisted of history and physical examination by the neurological surgeon and radiation oncologist, as well as detailed visual function evaluation by an ophthalmologist, most often a neuroophthalmologist. Patients were followed on a regular basis by the same physicians and underwent
Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma

107

108

B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister

 

 

 

 

MRI scans of the brain every 6 months, then every 12

Contrast-enhanced CT data are obtained in the frame

 

months.

with a localization cage attached. The patient is removed

 

Gross Tumour Volume (GTV) was defined on MRI

from the frame and a gadolinium enhanced MR scan is

 

images, fused to the orbital CT scans. GTV comprised

obtained next. Both imaging datasets are electronically

 

the tumour alone and not the entire optic nerve. No

transferred to the treatment planning workstation where

 

margin was added to the GTV to create CTV or PTV.

they are fused into one composite image for treatment

 

Normal structures which were routinely contoured in-

planning purposes. Due to the high spatial fidelity of

 

cluded the optic nerves, optic chiasm, eye globes and

CT data, the CT dataset is an obligatory imaging dataset

 

lenses. The maximum allowed dose to the optic chiasm

for treatment planning. The patient is discharged home

 

was in the range of 54–57 Gy, depending on the circum-

and returns for treatment inception usually a week to 10

 

stances. Dose Volume Histograms (DVH) were always

days later. In the X-Knife system the dose is delivered by

 

used to assess the dose distribution to the GTV and

using the arc rotation of the linac radiation beam around

 

normal organs.

the linac isocenter. Beam collimation is accomplished

 

 

using circular collimators (cones) ranging from 0.5 cm

 

10.3.1.1.1

to 5 cm in diameter. For single isocenter treatment, the

 

treatment planning relays on selecting the cone size,

 

X-Knife-based SRT with Relocatable Frame

which covers the target and placing a number of arcs

 

and Multiple Isocenter Technique

to deliver the radiation dose (Fig. 10.2). For irregular

 

For X-Knife-based SRT, the pre-treatment patient prep-

targets multiple cones, each placed at a new isocenter,

 

can be combined to cover the target (Fig. 10.3). Adjust-

 

aration involves the customized design of a lightweight

ing the placement, lengths and weights of the arcs and

 

relocatable frame – the Gill-Thomas-Cosman (GTC)

the weights of the isocenters, can shape the dose cloud

 

frame (Kooy et al. 1994) , which is a large “halo” de-

(Fig. 10.4).

 

vice that is attached to the patient with custom molded

Because of the linear shape of ONSM, the X-Knife

 

devices that fit into the oral cavity (based on dental

treatmentPROOFSplanning and delivery necessarily involved

 

impression of patient’s upper dentition) and conform

multiple overlapping isocenters. This created dose inho-

 

to the shape of the occipital region at the back of the

D

 

Emogeneity along the axis of the optic nerve. With the

 

head (Fig. 10.1). Day-to-day accuracy of the GTC frametadvent of the Novalis unit, we have since adopted treat-

 

can be verified using a special device called the “depthC

ments based on a single isocenter which are much more

 

conformation helmet”, a plastic hemispherical shellEthat

efficient and which yield much higher dose homogene-

 

allows for the measurement of the distanceRbetween

ity along the axis of the optic nerve with dynamic arc

 

the shell and the head surface at a numberRof locations.

technique.

 

CO

 

Fig. 10.1. The Gill-Thomas-Cosman relocatable frame

Fig. 10.2. X-Knife treatment with single collimator and mul-

 

tiple arcs of various lengths and orientations

978-3-540-77557-7_1_2008-08-06_1

Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma

109

 

 

Fig. 10.3. For irregular targets, such as ONSM, multiple cones,

Fig. 10.4. X-Knife treatment with multiple isocenters for

each placed at a new isocenter, can be combined to cover the

ONSM. The dose cloud is shaped by adjusting the isocenters

target

 

 

weight and arcs lengths, placements and weights

10.3.1.1.2

 

 

anteriorPROOFScomponents. In addition to the two anterior

The BrainLab/Novalis SRT System

 

 

parts, a special nose bridge is molded from thermoplas-

with Mini-multileaf Collimator

 

 

D

 

 

Etic beads to minimize head rotation during reposition-

 

ting. All components are mounted on a U-shaped metal

Patients can be treated on the Novalis system eitherCus-

frame and locked together with a set of plastic clips

ing the GTC frame or a multi-component thermoplasE

-

with adjustable spacers to allow for the mask shrinkage

tic head mask (BrainLab, Germany), which Ris custom-

(Fig. 10.5a). The Novalis treatment-planning worksta-

fitted to the shape of the patient’s head (GeorgR

et al. tion provides a number of planning options ranging

2006). The mask consists of one posterior shell and two

from dynamic arc treatment, to conformal static arcs or

CO

 

 

 

N

 

 

 

a

b

Fig. 10.5a,b. BrainLab’s thermoplastic head mask (a) and isodose distribution in ONSM patient (b)

978-3-540-77557-7_1_2008-08-06_1

110

B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister

 

 

 

 

 

 

 

 

stereotactic IMRT (Solberg et al. 2001). At our insti-

 

 

 

 

 

 

 

 

 

 

 

 

tution, most treatment plans involve a single isocenter

 

 

 

 

 

 

 

 

 

 

 

 

treatment with five non-coplanar arcs utilizing the dy-

 

 

 

 

 

 

 

 

 

 

 

 

namic arc method. With micro-multileaf collimation,

 

 

 

 

 

 

this technique allows for both high target conformality

 

 

 

 

 

 

 

 

 

 

 

 

and high dose homogeneity (Fig. 10.5b).

 

 

 

 

 

 

 

We published our initial results of SRT for ONSM

 

 

 

 

 

 

 

 

 

 

 

 

involving 33 optic nerves in 30 patients in 2002 (An-

 

 

 

 

 

 

drews et al. 2002). The median prescription dose was

 

 

 

 

 

 

 

 

 

 

 

 

51 Gy (range: 50.4–54 Gy) and the median follow-up, 21

 

 

 

 

 

 

months. Of 22 optic nerves with vision before SRT, 20

 

 

 

 

 

 

 

 

 

 

 

 

nerves (92%) demonstrated preserved vision and 42%

 

 

 

 

 

 

manifested improvement in visual acuity and/or visual

 

 

 

 

 

 

 

 

 

 

 

 

fields. Four patients (13%) had post-treatment morbidi-

 

 

 

 

 

 

ties, including visual loss (two patients), optic neuritis

 

 

 

 

 

 

 

 

 

 

 

 

(one patient) and transient orbital pain (one patient). At

 

Fig. 10.7. Early improvement in visual acuity in a patient with

 

the time of publication, no tumour progression was re-

 

right ONSM treated with SRT

 

ported on MRI scans. Six patients were monitored with

 

 

 

 

 

 

111In-octreotide scintigraphy which demonstrated sig-

 

 

 

 

 

 

nificant metabolic responses following SRT.

 

 

10.3.1.2

 

 

 

Most recently, we updated our experience (up

 

 

 

 

to 2006) to include a total of 50 patients with ONSM

 

BrainLAB technique (Barcelona, Spain)

 

(manuscript in preparation). Follow-up data were avail-

 

Since 2000 this technique has been available at de-

 

able for 38 patients (one treated to both eyes), with 12

 

 

lost to follow up. Five patients had no light perception

 

 

D

 

 

partmentsPROOFSof Radiation Oncology of Centro Médico

 

in the involved eye on presentation (one lost to FU).

 

Teknon-CMT, and Catalan Institute of Oncology-ICO,

 

Among the remaining 34 patients with vision on pre-

Eboth in Barcelona, Spain.

 

sentation, 20 (59%) experienced improvement in visualt

 

Radiation therapy planning was done in several

 

acuity and/or visual fields and 11 (32%) had stableCvi-

 

phases:

 

sion, for a total of 31/34 (91%) preserving vision.EThree

 

1. Immobilization with triple thermoplastic mask

 

patients (9%) had worse vision, in one case attributedR

to

 

 

(Figs. 10.8a,b–10.11a,b). Material for positioning is

 

tumour progression. One of the two remainingR received

 

 

composed by head resting-place that includes head-

 

SRT with the BrainLab system.

 

CO

 

 

 

rest, mask ring, screws for fixing vertical posts and

 

 

N

 

 

 

cam locks to put into cube for checking coordinates.

 

Two cases below illustrate an improvement in visual

 

 

 

fields (Fig. 10.6) and an early visual acuity improvement,

 

 

The non-invasive triple mask (top, rear, and middle

 

u

 

 

 

 

mask) enables precise and easy repeatable patient

 

occurring during the SRT course and within 3 months

 

 

 

from SRT completion (Fig. 10.7). Such an early effect is

 

 

fixation. The mask of thermo-transformable material

 

not rare and it is difficult to explain biologically.

 

 

 

is individually moulded for each patient and secured

 

 

 

 

 

 

 

to the mask ring (BrainLAB 2000; Villà et al. 2000;

 

 

 

 

 

 

 

Brell et al. 2006). Mask should be heated in water

 

 

 

 

 

 

 

to 70–80 °C. Different steps are needed to mould

 

 

 

 

 

 

 

the entire mask. Patient’s head is left and snap the

 

 

 

 

 

 

 

mask onto the upper side of the vertical posts and

 

 

 

 

 

 

 

put down onto the headrest. In approximately 1 min

 

 

 

 

 

 

 

mask material is hardening. After that, middle mask

 

 

 

 

 

 

 

is placed in the centre of the middle’s face, carefully

 

 

 

 

 

 

 

stretched. A T-shaped form nose bridge mould is

 

 

 

 

 

 

 

added to the middle mask using rolled loose pellets

 

 

 

 

 

 

 

after heating to optimize head fixation. The next step

 

 

 

 

 

 

 

is to place the top mask centrally over the patient’s

 

Fig. 10.6. Humphrey automated perimetry (24-2 central

 

 

face ensuring that the curve in the mask is placed

 

threshold) of left visual field in patient with left ONSM at pre-

 

 

towards the patient’s mouth, but does not cover it.

 

treatment (left) and at 11 months after SRT (right)

 

 

 

Top mask is secured by clips. Different clips and

978-3-540-77557-7_1_2008-08-06_1

Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma

111

 

 

a

b

N

 

 

u

Fig. 10.9. Head resting-place at time of treatment at coach position before starting RT session

Fig. 10.8a,b. Immobilization system – material for positioning and head fixation.

aHead resting-place: 1 – headrest, 2 – mask ring, 3 – screws, 4 – vertical posts, 5 – cam locks.

bMask system. Courtesy

of BrainLAB, Heimstetten,

Germany

Fig. 10.10. Head fixation using a triple thermo-plastic mask at time of treatment. Arrow shows an additional dental support strip for superior maxillary fixation

978-3-540-77557-7_1_2008-08-06_1

112 B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister

a

b

Fig. 10.11. a Head fixation using a triple thermo-plastic mask

detected. b Lenses defined on each control CT scan (drawn in

at time of treatment. Arrow shows a plastic clip (with five dif-

different colours) and the respective lenses defined on the plan-

ferent thickness from 0 mm to 4 mm). It permits a comfort-

ning CT after CT-to-CT skull registration (Miralbell et al.

able positioning for every patient regarding change of weigh

2007)

(for corticosteroids or malnutrition). No errors in precision are

 

spacers are needed to adapt size and head anatomy

 

 

and projected on to the respective CT sets. CT scans

for every patient and fix rear mask to top mask. An

 

 

are used for dosimetric calculations.

additional dental support strip for superior maxil-

 

D

PROOFSDefinition of target volumes (GTV=CTV, and

 

 

 

lary fixation is added to improve its quality.

 

 

 

PTV) could be done in any of images (only CT scan

Position of ocular balls. Eyes should be closed

E volume definition is very useful in some patients;

for simulation and treatment. Patients are requiredt

 

see Fig. 10.12). GTV and CTV are defined as the

to close gently both eyes on MRI scan and onCCT

 

 

whole optic nerve due to the difficulty to separate

scan, and for every session thereafter. WithEthis

 

 

tumour itself of the rest of nerve in many cases. PTV

simple movement, we reported that marginsR

of

 

 

is defined with a margin of 3 mm (Miralbell et al.

3 mm around the target may be necessaryR to safely

 

 

2007). As a rule, all the following OARS have to be

 

CO

 

 

 

defined: retina, contra-lateral optic nerve, chiasm,

treat these tumours under ideal set-up conditions.

 

 

N

 

 

 

lens, brain-stem, lachrymal gland, and pituitary.

Experience from ocular melanoma was translated

 

 

to ONSM (Miralbell et al. 2007). As can be seen

 

3.

Dosimetry. Any of the facilities from TPS could be

u

 

 

 

 

used such as conventional circular arc radiosurgery

in Fig. 10.11, lenses for ipsilateral affected eye was

 

 

used to be defined on each control CT scan and the

 

 

(RS), dynamic arc RS, conformal RS using multiple

respective lenses defined on the planning CT after

 

 

static shaped beams (Fig. 10.13), and IMRS imple-

CT-to-CT skull registration.

 

 

 

 

mented by either static or dynamic micro multi-leaf

2. Co-registration of CT and MRI. After cranial immo-

 

 

collimator (mMLC) techniques (Fig. 10.14). The

bilization, all patients underwent a planning CT scan

 

 

so-called m3 mMLC “moulds” target shape in any

with fiducial rods attached to the head frame. CT im-

 

 

angle and field (beam eye view).

ages are obtained from the scalp vertex through the

 

4. Dose. Prescribed total dose ranges between 50 and

brain using 2–3 mm thick slices (acquisition time is

 

 

54 Gy at ICRU point, 25–30 fractions, 1.8–2 Gy per

of 30–40 s) and transferred to the treatment plan-

 

 

fraction, once a day (Fig. 10.15).

ning system (TPS), BrainScan 5.1 (BrainLAB A.G.,

 

5.

OARS. Contra-lateral optic nerve, chiasm, lens,

Heimstetten, Germany). Contrast for CT is used in

 

 

lachrymal gland, pituitary, brain-stem, and retina

some cases. CT to MRI registration is performed for

 

 

are systematically drawn (Fig. 10.15).Optimal or-

each patient by automatic alignment of bone struc-

 

 

gan dose constraints are as follows: retina: 50 Gy;

tures on the two image sets. Target volumes and or-

 

 

lens: 9 Gy; optic nerve and chiasm: 55 Gy; lacrymal

gans at risk (OARs) are defined on the MR images

 

 

gland: 30 Gy

978-3-540-77557-7_1_2008-08-06_1

ED t C

Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma

113

 

 

Fig. 10.12. Isodoses distribution on the PTV. The patient was planned using the CT scan

Fig. 10.14. Image of the m3 micromultileaf collimator (beam eye view)

Fig. 10.13.PROOFSIn this figure it can be seen an example of five fix fields conformed by micromultileaf m3 collimator. The colli-

sion map to guarantee no accidents at the treatment set up can also be observed

Fig. 10.15. Dose Volume Histogram (DVH) for GTV and PTV, and most relevant organs at risk for the specific case

978-3-540-77557-7_1_2008-08-06_1

114 B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister

Dose Volume Histogram (DVH) must always be done and displayed for GTV, CTV and PTV, and for most relevant organs at risk for every specific case (Fig. 10.15).

Treatment was performed using a radiosurgery-ded- icated 6-MV X-ray beam linear accelerator with a built-in m3 mMLC (Figs. 10.14 and 10.16) (Novalis®, BrainLAB, Heimstetten, Germany). It was installed at Centro Médico Teknon in Barcelona in 2000. This treatment system is able to operate in several modalities (see above). For treatment set-up a cube for checking coor-

dinates is used every fraction to assure minimal isocenter error and good quality assurance (Fig. 10.17). This cube enables one to check the origin of the coordinates (coordinates 0,0,0) at the beginning of set-up and to move to the PTV coordinates.

Three different laser projections (two laterals and one superior-saggital) are projected on coordinates cube and on patient mask (Figs. 10.18 and 10.19). In relation to final dosimetry, different coach and gantry angles are needed to accomplish treatment agreed between physicians and physicists. Coach position must be checked inside the bunker (Fig. 10.16).

 

 

 

t

 

 

 

C

Fig. 10.16. In relation to final dosimetry, different coach and

 

 

E

gantry angles are needed to accomplish treatment agreed be-

 

 

R

 

tween physicians and physicists. Treatment position. Table and

gantry rotation for a specific treatment field

R

 

CO

 

 

Fig. 10.18. Triple room lasers for checking patient position: lateral laser (A) and superior (saggital) laser (B)

Fig. 10.17. Cube for checking the origin coordinates (coordinates 0,0,0) and the PTV coordinates (arrow)

Fig. 10.19. Triple room lasers for checking patient position. Simulation of the isocenter on the centre of the orbit

978-3-540-77557-7_1_2008-08-06_1

 

Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma

115

 

 

 

 

 

10.3.1.3

 

 

mobilisation systems deal with the whole treatment

 

university of tuebingen, Germany Approach

 

unit including a visualisation tool (CT) at the LINAC

 

At Tuebingen, conformal radiotherapy of optic nerve

 

and a robotic table also being able to compensate for

 

 

rotational errors.

 

sheath meningioma has been performed with 6-MV

 

For the approach described in the following section,

 

photons and a conventional fractionation scheme at a

 

a rigid relocatable immobilisation mask system with a

 

linear accelerator (LINAC) employing a non-invasive

 

mean accuracy of 0.8 ± 0.6 mm is used. In an analysis of

 

rigid mask immobilisation system designed at the Ger-

 

our first patients 95% of all absolute measures were less

 

man Cancer Research Center, Heidelberg, since 1993

 

than 2.8 mm for transition to the LINAC and 4.6 mm

 

(Schlegel et al. 1992; Becker et al. 2002a). Treatment

 

during treatment (Kortmann et al. 1999). The isocen-

 

planning precedes an interdisciplinary board discussing

 

ter setup is performed with a stereotactic localization

 

the indication and target extension for treatment. The

 

system described in Becker et al. (2002a) using ste-

 

target volume comprises the gross visible optic nerve

 

reotactic coordinates. Stereotactic coordinates are used

 

sheath tumour. If this is not clearly distinguishable, the

 

for the transfer of the isocenter to the patient within the

 

whole optic nerve (GTV) covering the anatomical re-

 

immobilisation mask. The process of treatment plan-

 

gion of ophthalmological functional deficits, enlarged

 

ning starts with the building of the special removable

 

by necessary safety margins of the used mask immo-

 

immobilisation mask system. The mask is made of cast

 

bilisation system represents the planning target volume

 

material. For its creation the patient lies supine on a

 

(PTV). Organs at risk (OARs) in close vicinity such as

 

treatment couch with his head resting in an extension

 

chiasm, optical nerve, eye globes, lenses, brain stem or

 

made of two curved wooden plates around which the

 

the brain itself are segmented in the planning computed

 

cast material is rolled (Fig. 10.20). The extension is

 

tomography (CT) slices. The treatment planning is

 

necessary to avoid dosimetric disturbances due to the

 

performed with a commercial planning system (Helax

 

treatment couch for posterior entry portals or collision

 

TMS) employing non-coplanar, wedged and individu-

 

between gantry and couch. This enables a wide range

 

ally shaped small treatment portals. A fractionation of

 

of non-PROOFScoplanar beams. After hardening of the material

 

5 × 1.8 Gy/week up to 54 Gy is used. The immobilisation

 

(about 30–45 min) the mask is cut from chin to above

 

of the patient to treat this vulnerable region has to be

 

D

 

Ethe ear region to allow the patient to leave and re-en-

 

optimised for the correct daily beam application. Sevt-

ter the mask (Fig. 10.21) with reasonable comfort. For

 

eral principles can be used to achieve this goal. A Crela-

 

planning and treatment the mask is closed with simple

 

tively simple method is the usage of a rigid maskEsystem

 

fixation locks at each side. The patient holds an emer-

 

with well known immobilisation errors thatRare taken

 

gency trip wire to be able to release the mask fixation

 

into account in the definition of the PTV. TheRindividual

 

locking (Fig. 10.20).

 

set-up control is described below. More advanced im-

 

 

 

 

CO

 

 

 

N

 

 

 

u

 

 

 

 

Fig. 10.20. Mask made of casting material rolled around wood-

Fig. 10.21. Jaw of the mask and patients’ entrance into the

en plates, removable fixation for the patients’ emergency exit

mask

978-3-540-77557-7_1_2008-08-06_1

116

B. Jeremić, M. W. Wasik, S. Villà, F. Paulsen, G. Bednarz, D. Linero and M. Buchgeister

 

 

 

 

During treatment planning a diagnostic MRI and

the beams’ eye view function of the RTP. The treatment

 

the planning CT are fused (e.g. by mutual information

plan is iteratively optimized to achieve a dose distribu-

 

algorithms) in the radiation treatment planning system

tion according to the guidelines defined by the ICRU

 

(RTP) and checked by an experienced radiation oncolo-

50 report. PTV and OARs define the geometry of each

 

gist. A stereotactic localisator, that is mounted over the

field such that 95% of the prescribed dose surrounds

 

fixation mask (Fig. 10.22) defines the stereotactic coor-

the PTV. An experienced treatment planning team usu-

 

dinate system for the patients’ anatomy inside the mask.

ally achieves a homogeneous dose distribution for the

 

The planning CT includes the whole head from the top

PTV. The dose to brain stem, chiasm or optical nerves

 

of the scull to the neck to allow for the planning of non-

should not exceed 54–55 Gy in 1.8-Gy fractions, the

 

coplanar treatment beams and to estimate the beam

dose to the other OARs being as described above in this

 

direction inside the body (Fig. 10.23). The slice thick-

chapter. Usually 5–6 wedged fields are used. The posi-

 

ness is in the range of 2–3 mm in the region of the PTV

tion of the isocenter for treatment is defined within the

 

to get adequate resolution of the different small sized

stereotactic localisator at the CT. Three translations are

 

organs. As the planning CT and a high resolution MRI

given to move the patient from the stereotactic coordi-

 

is co-registered for target volume definition, a contrast

nate (0;0;0) to the coordinates of the isocenter (X;Y;Z)

 

media enhanced planning CT is not also necessary. Sec-

(Fig. 10.25) at the set-up for treatment. The z-coordinate

 

ond, due to the rigid mask system, there is a higher risk

is defined by the distance “A” of the metal markers at the

 

for severe complications in case of allergic reactions

surface of the stereotactic localisation tool (Figs. 10.22

 

3.6 Gy, the PTV is reduced by adding only 2 mm safety

trolled PROOFSbefore treatment by comparison of the block’s

 

to the contrast media when such a CT is taken. After

and 10.25). Two orthogonal verification beams of stan-

 

co-registration of the planning CT and the MRI, tar-

dardized field size of 8 × 8 cm2 are created and digital

 

get volumes (GTV, organs at risk) are delineated. The

reconstructed radiographs (DRR) are printed for fol-

 

PTV is generated by adding 5 mm to the GTV for the

lowing setup verifications at the LINAC. Individualized

 

treatment plan that is used for the first 28 fractions up

shielding is achieved by usage of conventional shielding

 

to 50.4 Gy (Fig. 10.24). For the boost of an additional

blocks made of MCP96. Every shielding block is con-

 

margin around the GTV.

 

D

 

 

light field shape at the LINAC with the scaled beam’s

 

Optimal beam angles are determined during the

Eoutline printed on paper (Fig. 10.26). The deviation of

 

 

C

 

 

radiation treatment planning process with the help oftthe resulting field has to be in a clinical acceptable range

 

E

 

 

R

 

 

Fig. 10.22. Planning stereotactic localisation tool mounted over the mask; diagonal radiopaque lines with defined distance “A”

Fig. 10.23. Isodose distribution in a sagittal reconstruction estimating the bodies distribution

978-3-540-77557-7_1_2008-08-06_1